Meridian Bioscience Inc reports results for the quarter ended in September - Earnings Summary

VivoPower

22/11/2022 14:04

* Meridian Bioscience Inc  VIVO.OQ  reported quarterly
adjusted
earnings of 21 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for earnings of 15 cents per share.
    * Revenue fell 13.8% to $65.68 million from a year ago;
analysts
expected $67.43 million. 
    * Meridian Bioscience Inc's reported EPS for the quarter was
13
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Meridian Bioscience Inc shares had risen by 1.5% this
quarter and gained 56.9% so far this year.
    * The company reported quarterly net income of $5.71
million.
    * Wall Street's median 12-month price target for Meridian
Bioscience Inc is $34.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
22 at 02:04 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.15           0.21           Beat
 Jun. 30 2022      0.16           0.16           Met
 Mar. 31 2022      0.48           0.66           Beat
 Dec. 31 2021      0.25           0.35           Beat